Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis

Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis

IntroductionMultiple sclerosis (MS) is a potentially disabling disease that damages the brain and spinal cord, inducing paralysis of the body. While MS has been known as a T-cell mediated disease, recent attention has been drawn to the involvement of B cells in its pathogenesis. Autoantibodies from...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, Yoe-Sik Bae
Materialtyp: Artikel
Språk:English
Publicerad: Frontiers Media S.A. 2023-06-01
Serie:Frontiers in Immunology
Ämnen:
sphingosylphosphorylcholine
plasma cells
S1PR3
experimental autoimmune encephalomyelitis
multiple sclerosis
Länkar:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151511/full

Liknande verk

Liknande verk